QT Vascular awarded Medical Device Directive approval

QT Vascular, a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease,have gained a CE mark under the Medical Device Directive (MDD) for its unique peripheral drug-coated balloon, Chocolate® Touch.

Based in Singapore with a US subsidiary, TriReme Medical LLC is an emerging leader in the development and commercialization of next generation minimally invasive products for the treatment of complex vascular disease. QT Vascular works closely with leading physicians and scientists from around the world to create differentiated devices that improve procedural and clinical outcomes.

The full story is available here.